Learn more →
Back to Expert Scholars
cancer-biology / cancer-biologyCancer Drug Resistance

René Bernards

勒内·伯纳兹

PhD

🏢Netherlands Cancer Institute(荷兰癌症研究所)🌐Netherlands

Professor of Molecular Carcinogenesis; Head, Division of Molecular Carcinogenesis分子致癌学教授;分子致癌学部门主任

80
h-index
3
Key Papers
3
Awards
3
Key Contributions

👥Biography 个人简介

René Bernards is a leading authority on cancer drug resistance and genetic functional screens at the Netherlands Cancer Institute. His laboratory pioneered large-scale RNAi and CRISPR screens to identify mechanisms of resistance to targeted therapies, particularly in BRAF-mutant melanoma and colorectal cancer, informing combination therapy strategies.

Share:

🧪Research Fields 研究领域

Genetic Screens遗传筛选
Drug Resistance耐药性
RAS SignalingRAS信号通路
BRAF-Mutant CancerBRAF突变癌症
Synthetic Lethality合成致死

🎓Key Contributions 主要贡献

Genetic Screens for Drug Resistance

Pioneered genome-wide RNAi loss-of-function screens to identify genes whose suppression confers resistance or sensitivity to targeted cancer therapies, including BRAF and MEK inhibitors.

BRAF Inhibitor Resistance Mechanisms

Identified key mechanisms of intrinsic and acquired resistance to BRAF inhibitors in melanoma and colorectal cancer, including EGFR feedback activation and KRAS amplification.

Oncogene Addiction and Synthetic Lethality

Developed functional approaches to exploit cancer-specific vulnerabilities, identifying synthetic lethal interactions that can be targeted in RAS-driven and other cancers.

Representative Works 代表性著作

[1]

An shRNA barcode screen provides insight into cancer cell vulnerability and oncogene addiction

Nature Medicine (2006)

Demonstrated the power of shRNA pooled screens for identifying oncogene dependencies and predicting sensitivity to targeted cancer therapies.

[2]

Melanoma: Escaping the trap

Nature (2012)

Described mechanisms by which BRAF-mutant melanoma cells escape BRAF inhibition through ERK reactivation and vertical pathway bypass.

[3]

A genetic screen identifies TCF3 as a suppressor of EMT and the invasion program

Nature Cell Biology (2014)

Identified TCF3 as a key transcriptional suppressor of EMT, providing new mechanistic insights into epithelial plasticity in cancer.

🏆Awards & Recognition 奖项与荣誉

🏆Dutch Cancer Society Willem Waterschoot van der Gracht Award
🏆AACR Joseph H. Burchenal Clinical Research Award
🏆ERC Advanced Grant

📄Data Sources 数据来源

Last updated: 2026-01-15 | All information from publicly available academic sources

关注 勒内·伯纳兹 的研究动态

Follow René Bernards's research updates

留下邮箱,当我们发布与 René Bernards(Netherlands Cancer Institute)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment